Mars will acquire US-based whole-fruit snacking brand Trü Frü to broaden its health and wellness portfolio.
Tru Fru will operate as an independent business and continue to be led by CEO, Brian Neville.
According to Neville, Mars shares a passion for healthier snacking and has the capabilities to take their company to the next level.
The transaction is subject to customary regulatory approvals and is expected to close in the first quarter of 2023.
Headquartered in West Valley City, Utah, with approximately 50 employees,
Trü Frü’s snacks are available in frozen and shelf-stable formats in US retailers.
Andrew Clarke noted that Trü Frü is a perfect complementary fit for their health and wellness portfolio, and their capabilities will help the brand strengthen its operations, broaden distribution and accelerate growth.
He added that Mars wants to be the preferred home for emerging and founder-led brands like Trü Frü.


Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
US Auto Industry Urges Trump to Block Chinese EV Market Access
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Asian Stocks Slip as Korea’s KOSPI Tumbles Amid Iran Conflict and Chip Sector Profit-Taking
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
Why financial hardship is more likely if you’re disabled or sick
Gold Prices Slip as Strong Dollar and Rising Oil Weigh on Market Sentiment
Why a ‘rip-off’ degree might be worth the money after all – research study
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Armani Group Eyes Strategic Stake Sale to Luxury Giants
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns 



